chemotherapy: be vs iv chemotherapy

from Quasimodo
0.2 0.4 0.6 0.8 Plausible Typical Remarkable Salient

Related concepts

Parents treatment
Weight: 0.64
, regimen
Weight: 0.62
, modality
Weight: 0.61
, agent
Weight: 0.60
, prostate cancer
Weight: 0.59
Siblings gene therapy
Weight: 0.66
, breast cancer
Weight: 0.36
, dialysis
Weight: 0.36
, transplant
Weight: 0.34
, mastectomy
Weight: 0.34

Related properties

Property Similarity
be vs iv chemotherapy 1.00
be vs immunotherapy 0.80
be vs lumpectomy 0.80
be vs radiation 0.79
be better than radiotherapy 0.78
be effective in cancer treatment 0.78
be administered to lymphoma patient 0.77
be with primaquine initiate hemolytic anemia 0.76

Priors about this statement

Cues

0.2 0.4 0.6 0.8 Joint Necessity Sufficiency Implication Entailment Contradiction Entropy

Evidence

0.2 0.4 0.6 0.8 Plausible Typical Remarkable Salient

Clauses

Plausibility inference from child typicality

0.50
Rule weight: 0.66
Evidence weight: 0.97
Similarity weight: 0.78
Evidence: 0.85
Plausible(agent, be effective in cancer treatment) ⋁
Evidence: 0.17
¬ Typical(chemotherapy, be vs iv chemotherapy)
0.50
Rule weight: 0.66
Evidence weight: 0.99
Similarity weight: 0.76
Evidence: 0.92
Plausible(treatment, be with primaquine initiate hemolytic anemia) ⋁
Evidence: 0.17
¬ Typical(chemotherapy, be vs iv chemotherapy)

Plausibility inheritance from parent to child

0.04
Rule weight: 0.09
Evidence weight: 0.50
Similarity weight: 0.78
Evidence: 0.41
Plausible(chemotherapy, be vs iv chemotherapy) ⋁
Evidence: 0.85
¬ Plausible(agent, be effective in cancer treatment)
0.03
Rule weight: 0.09
Evidence weight: 0.45
Similarity weight: 0.76
Evidence: 0.41
Plausible(chemotherapy, be vs iv chemotherapy) ⋁
Evidence: 0.92
¬ Plausible(treatment, be with primaquine initiate hemolytic anemia)

Remarkability exclusitivity betweem a parent and a child

0.27
Rule weight: 0.58
Evidence weight: 0.60
Similarity weight: 0.78
Evidence: 0.95
¬ Remarkable(chemotherapy, be vs iv chemotherapy) ⋁
Evidence: 0.43
¬ Remarkable(agent, be effective in cancer treatment)
0.25
Rule weight: 0.58
Evidence weight: 0.57
Similarity weight: 0.76
Evidence: 0.95
¬ Remarkable(chemotherapy, be vs iv chemotherapy) ⋁
Evidence: 0.45
¬ Remarkable(treatment, be with primaquine initiate hemolytic anemia)

Remarkability exclusitivity between siblings

0.03
Rule weight: 0.13
Evidence weight: 0.30
Similarity weight: 0.80
Evidence: 0.95
¬ Remarkable(chemotherapy, be vs iv chemotherapy) ⋁
Evidence: 0.73
¬ Remarkable(mastectomy, be vs lumpectomy)

Remarkability from parent implausibility

0.33
Rule weight: 0.42
Evidence weight: 1.00
Similarity weight: 0.78
Evidence: 0.85
Plausible(agent, be effective in cancer treatment) ⋁
Evidence: 0.95
Remarkable(chemotherapy, be vs iv chemotherapy) ⋁
Evidence: 0.41
¬ Plausible(chemotherapy, be vs iv chemotherapy)
0.32
Rule weight: 0.42
Evidence weight: 1.00
Similarity weight: 0.76
Evidence: 0.92
Plausible(treatment, be with primaquine initiate hemolytic anemia) ⋁
Evidence: 0.95
Remarkable(chemotherapy, be vs iv chemotherapy) ⋁
Evidence: 0.41
¬ Plausible(chemotherapy, be vs iv chemotherapy)

Remarkability from sibling implausibility

0.41
Rule weight: 0.60
Evidence weight: 0.85
Similarity weight: 0.80
Evidence: 0.41
Plausible(chemotherapy, be vs iv chemotherapy) ⋁
Evidence: 0.73
Remarkable(mastectomy, be vs lumpectomy) ⋁
Evidence: 0.93
¬ Plausible(mastectomy, be vs lumpectomy)

Salient implies Plausible

0.17
Rule weight: 0.28
Evidence weight: 0.59
Similarity weight: 1.00
Evidence: 0.41
Plausible(chemotherapy, be vs iv chemotherapy) ⋁
Evidence: 0.69
¬ Salient(chemotherapy, be vs iv chemotherapy)

Similarity expansion

0.67
Rule weight: 0.85
Evidence weight: 0.98
Similarity weight: 0.80
Evidence: 0.17
Typical(chemotherapy, be vs iv chemotherapy) ⋁
Evidence: 0.02
¬ Typical(chemotherapy, be vs immunotherapy)
0.65
Rule weight: 0.85
Evidence weight: 0.95
Similarity weight: 0.80
Evidence: 0.95
Remarkable(chemotherapy, be vs iv chemotherapy) ⋁
Evidence: 0.99
¬ Remarkable(chemotherapy, be vs immunotherapy)
0.64
Rule weight: 0.85
Evidence weight: 0.95
Similarity weight: 0.79
Evidence: 0.95
Remarkable(chemotherapy, be vs iv chemotherapy) ⋁
Evidence: 0.97
¬ Remarkable(chemotherapy, be vs radiation)
0.64
Rule weight: 0.85
Evidence weight: 0.95
Similarity weight: 0.79
Evidence: 0.17
Typical(chemotherapy, be vs iv chemotherapy) ⋁
Evidence: 0.06
¬ Typical(chemotherapy, be vs radiation)
0.64
Rule weight: 0.85
Evidence weight: 0.96
Similarity weight: 0.78
Evidence: 0.17
Typical(chemotherapy, be vs iv chemotherapy) ⋁
Evidence: 0.05
¬ Typical(chemotherapy, be better than radiotherapy)
0.64
Rule weight: 0.85
Evidence weight: 0.97
Similarity weight: 0.77
Evidence: 0.95
Remarkable(chemotherapy, be vs iv chemotherapy) ⋁
Evidence: 0.68
¬ Remarkable(chemotherapy, be administered to lymphoma patient)
0.63
Rule weight: 0.85
Evidence weight: 0.95
Similarity weight: 0.78
Evidence: 0.95
Remarkable(chemotherapy, be vs iv chemotherapy) ⋁
Evidence: 0.98
¬ Remarkable(chemotherapy, be better than radiotherapy)
0.59
Rule weight: 0.85
Evidence weight: 0.86
Similarity weight: 0.80
Evidence: 0.41
Plausible(chemotherapy, be vs iv chemotherapy) ⋁
Evidence: 0.23
¬ Plausible(chemotherapy, be vs immunotherapy)
0.57
Rule weight: 0.85
Evidence weight: 0.83
Similarity weight: 0.80
Evidence: 0.69
Salient(chemotherapy, be vs iv chemotherapy) ⋁
Evidence: 0.53
¬ Salient(chemotherapy, be vs immunotherapy)
0.56
Rule weight: 0.85
Evidence weight: 0.83
Similarity weight: 0.79
Evidence: 0.41
Plausible(chemotherapy, be vs iv chemotherapy) ⋁
Evidence: 0.29
¬ Plausible(chemotherapy, be vs radiation)
0.56
Rule weight: 0.85
Evidence weight: 0.84
Similarity weight: 0.78
Evidence: 0.41
Plausible(chemotherapy, be vs iv chemotherapy) ⋁
Evidence: 0.27
¬ Plausible(chemotherapy, be better than radiotherapy)
0.56
Rule weight: 0.85
Evidence weight: 0.82
Similarity weight: 0.79
Evidence: 0.69
Salient(chemotherapy, be vs iv chemotherapy) ⋁
Evidence: 0.56
¬ Salient(chemotherapy, be vs radiation)
0.55
Rule weight: 0.85
Evidence weight: 0.82
Similarity weight: 0.78
Evidence: 0.69
Salient(chemotherapy, be vs iv chemotherapy) ⋁
Evidence: 0.57
¬ Salient(chemotherapy, be better than radiotherapy)
0.48
Rule weight: 0.85
Evidence weight: 0.72
Similarity weight: 0.77
Evidence: 0.69
Salient(chemotherapy, be vs iv chemotherapy) ⋁
Evidence: 0.88
¬ Salient(chemotherapy, be administered to lymphoma patient)
0.35
Rule weight: 0.85
Evidence weight: 0.53
Similarity weight: 0.77
Evidence: 0.41
Plausible(chemotherapy, be vs iv chemotherapy) ⋁
Evidence: 0.80
¬ Plausible(chemotherapy, be administered to lymphoma patient)
0.21
Rule weight: 0.85
Evidence weight: 0.32
Similarity weight: 0.77
Evidence: 0.17
Typical(chemotherapy, be vs iv chemotherapy) ⋁
Evidence: 0.83
¬ Typical(chemotherapy, be administered to lymphoma patient)

Typical and Remarkable implies Salient

0.13
Rule weight: 0.14
Evidence weight: 0.95
Similarity weight: 1.00
Evidence: 0.69
Salient(chemotherapy, be vs iv chemotherapy) ⋁
Evidence: 0.17
¬ Typical(chemotherapy, be vs iv chemotherapy) ⋁
Evidence: 0.95
¬ Remarkable(chemotherapy, be vs iv chemotherapy)

Typical implies Plausible

0.43
Rule weight: 0.48
Evidence weight: 0.90
Similarity weight: 1.00
Evidence: 0.41
Plausible(chemotherapy, be vs iv chemotherapy) ⋁
Evidence: 0.17
¬ Typical(chemotherapy, be vs iv chemotherapy)

Typicality and Rermarkability incompatibility between a parent and a child

0.04
Rule weight: 0.51
Evidence weight: 0.11
Similarity weight: 0.78
Evidence: 0.95
¬ Remarkable(chemotherapy, be vs iv chemotherapy) ⋁
Evidence: 0.94
¬ Typical(agent, be effective in cancer treatment)
0.03
Rule weight: 0.51
Evidence weight: 0.07
Similarity weight: 0.76
Evidence: 0.95
¬ Remarkable(chemotherapy, be vs iv chemotherapy) ⋁
Evidence: 0.98
¬ Typical(treatment, be with primaquine initiate hemolytic anemia)

Typicality and Rermarkability incompatibility between siblings

0.06
Rule weight: 0.14
Evidence weight: 0.54
Similarity weight: 0.80
Evidence: 0.95
¬ Remarkable(chemotherapy, be vs iv chemotherapy) ⋁
Evidence: 0.48
¬ Typical(mastectomy, be vs lumpectomy)

Typicality inheritance from parent to child

0.08
Rule weight: 0.48
Evidence weight: 0.22
Similarity weight: 0.78
Evidence: 0.17
Typical(chemotherapy, be vs iv chemotherapy) ⋁
Evidence: 0.94
¬ Typical(agent, be effective in cancer treatment)
0.07
Rule weight: 0.48
Evidence weight: 0.19
Similarity weight: 0.76
Evidence: 0.17
Typical(chemotherapy, be vs iv chemotherapy) ⋁
Evidence: 0.98
¬ Typical(treatment, be with primaquine initiate hemolytic anemia)